1-(2-Hydroxyethyl)piperazine → 6-(4-(2-Hydroxyethyl)piperazin-1-yl)-nicotinamide
반응식
Cl[C:2]1[CH:27]=[CH:26][C:5]([C:6]([NH:8]C2C=CC(Cl)=C(NC(=O)C3C=CC=C(Cl)C=3)C=2)=[O:7])=[CH:4][N:3]=1.[N:28]1([CH2:34][CH2:35][OH:36])[CH2:33][CH2:32][NH:31][CH2:30][CH2:29]1>>[OH:36][CH2:35][CH2:34][N:28]1[CH2:33][CH2:32][N:31]([C:2]2[CH:27]=[CH:26][C:5]([C:6]([NH2:8])=[O:7])=[CH:4][N:3]=2)[CH2:30][CH2:29]1참가 물질
3
실험 절차
6-chloro-N-(4-chloro-3-(3-chlorobenzamido)phenyl)nicotinamide (0.143 mmol) was used in general procedure 3 with 2-(piperazin-1-yl)ethanol (0.71 mmol). The product was purified by RP-HPLC to give N-(4-chloro-3-(3-chlorobenzamido)phenyl))-6-(4-(2-hydroxyethyl)piperazin-1-yl)-nicotinamide. MS (Q1) 498.0 (M)+
후처리
- customThe product was purified by RP-HPLC
출처 및 근거
- ORD 기록
- ord-24c334eef30540efa3f3281b117e5986
- 출처 데이터셋
- uspto-grants-2012_01
- 특허 번호
- US08101610B2
반응 노트
불러오는 중…